FMO2 <sup>+</sup> cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma
- DOI
- 10.1136/jitc-2025-011648
- Published
- 2025-05
- Container
- Journal for ImmunoTherapy of Cancer
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/jitc-2025-011648,
title = {FMO2
<sup>+</sup>
cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma},
author = {Wenxin Xu and Jialei Weng and Yufei Zhao and Peiyi Xie and Minghao Xu and Shaoqing Liu and Qiang Yu and Mincheng Yu and Bugang Liang and Junbo Chen and Hui-Chuan Sun and Hui Li and Qinghai Ye and Yinghao Shen},
year = {2025},
journal = {Journal for ImmunoTherapy of Cancer},
doi = {10.1136/jitc-2025-011648},
url = {https://doi.org/10.1136/jitc-2025-011648}
}RIS
TY - JOUR
TI - FMO2
<sup>+</sup>
cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma
AU - Wenxin Xu
AU - Jialei Weng
AU - Yufei Zhao
AU - Peiyi Xie
AU - Minghao Xu
AU - Shaoqing Liu
AU - Qiang Yu
AU - Mincheng Yu
AU - Bugang Liang
AU - Junbo Chen
AU - Hui-Chuan Sun
AU - Hui Li
AU - Qinghai Ye
AU - Yinghao Shen
PY - 2025
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2025-011648
UR - https://doi.org/10.1136/jitc-2025-011648
ER - APA
Xu, W., Weng, J., Zhao, Y., Xie, P., Xu, M., Liu, S., Yu, Q., Yu, M., Liang, B., Chen, J., Sun, H., Li, H., Ye, Q., & Shen, Y. (2025). FMO2 <sup>+</sup> cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2025-011648
Source records
- crossref · retrieved 2026-09-26T01:40:32.453Z